A 2025 meta-analysis of 12 RCTs involving more than 25,000 participants showed no elevated risk of any cancer type, including thyroid (RR 1.07, 0.225.12 p = 0.93), pancreatic (RR 0.85, 0.107.43 p = 0.89), or gastrointestinal malignancy (RR 0.73, 0.262.04 p = 0.54) [147]
accessed on 5 December 2025 [18]) indicating expression of both mRNA and protein across multiple tissue types including brain, liver, kidney, heart, pancreas and gastrointestinal tissues
In preclinical studies, ipamorelin has effects independent of GH, which underscores the need to monitor metabolic markers
Journal of Dietary Supplements, 18(4), 387-405
Do not drive if your blood sugar has been low
We are here to provide the tools, the technology, and the clinical expertise to make that journey as clear and supported as possible